Summary
355.48 1.37(0.39%)05/17/2024
West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. (WST)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.50 | 3.05 | -6.19 | -10.83 | 11.50 | 0.35 | 206.21 | 84,601.41 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 368.38 | |
| Open | 368.25 | |
| High | 368.85 | |
| Low | 364.45 | |
| Volume | 272,402 | |
| Change | 1.84 | |
| Change % | 0.50 | |
| Avg Volume (20 Days) | 459,567 | |
| Volume/Avg Volume (20 Days) Ratio | 0.59 | |
| 52 Week Range | 310.42 - 415.73 | |
| Price vs 52 Week High | -11.39% | |
| Price vs 52 Week Low | 18.67% | |
| Range | 0.04 | |
| Gap Up/Down | -0.92 | |
Fundamentals | ||
| Market Capitalization (Mln) | 25,575 | |
| EBIDTA | 808,099,968 | |
| PE Ratio | 53.1676 | |
| PEG Ratio | 3.2976 | |
| WallStreet Target Price | 457.00 | |
| Book Value | 29.7210 | |
| Earnings Per Share | 8.0630 | |
| EPS Estimate Current Quarter | 1.8000 | |
| EPS Estimate Next Quarter | 1.9000 | |
| EPS Estimate Current Year | 8.4900 | |
| EPS Estimate Next Year | 9.0500 | |
| Diluted EPS (TTM) | 8.0630 | |
| Revenues | ||
| Profit Marging | 0.2285 | |
| Operating Marging (TTM) | 0.2580 | |
| Return on asset (TTM) | 0.1510 | |
| Return on equity (TTM) | 0.3124 | |
| Revenue TTM | 2,680,999,936 | |
| Revenue per share TTM | 36.2420 | |
| Quarterly Revenue Growth (YOY) | 0.2890 | |
| Quarterly Earnings Growth (YOY) | 1.1190 | |
| Gross Profit (TTM) | 767,800,000 | |
| Dividends | ||
| Dividend Share | 0.6800 | |
| Dividend Yield | 0.0015 | |
| Valuations | ||
| Trailing PE | 53.1676 | |
| Forward PE | 50.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 14.5169 | |
| Revenue Enterprise Value | 11.7860 | |
| EBITDA Enterprise Value | 39.1940 | |
| Shares | ||
| Shares Outstanding | 74,079,696 | |
| Shares Float | 73,593,752 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.63 | |
| Institutions (%) | 93.58 | |
04/30 06:00 EST - prnewswire.com
West to Participate in Upcoming Investor Conference
EXTON, Pa. , April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT. A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com.
West to Participate in Upcoming Investor Conference
EXTON, Pa. , April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT. A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com.
04/25 17:42 EST - seekingalpha.com
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2024 Earnings Conference Call April 25, 2024 9:00 AM ET Company Participants Quintin Lai - Vice President, Strategy and Investor Relations Eric Green - President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial and Operations Officer Conference Call Participants Matt Larew - William Blair Jacob Johnson - Stephens Paul Knight - KeyBanc Michael Ryskin - Bank of America Justin Bowers - Deutsche Bank David Windley - Jefferies Larry Solow - CJS Securities Operator Good day, and thank you for standing by. Welcome to West Pharmaceutical Services First Quarter 2024 Earnings Conference Call.
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2024 Earnings Conference Call April 25, 2024 9:00 AM ET Company Participants Quintin Lai - Vice President, Strategy and Investor Relations Eric Green - President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial and Operations Officer Conference Call Participants Matt Larew - William Blair Jacob Johnson - Stephens Paul Knight - KeyBanc Michael Ryskin - Bank of America Justin Bowers - Deutsche Bank David Windley - Jefferies Larry Solow - CJS Securities Operator Good day, and thank you for standing by. Welcome to West Pharmaceutical Services First Quarter 2024 Earnings Conference Call.
04/25 11:35 EST - zacks.com
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
04/25 08:11 EST - zacks.com
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.98 per share a year ago.
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.98 per share a year ago.
04/25 07:11 EST - reuters.com
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
West Pharmaceutical Services on Thursday beat quarterly profit estimates and raised its annual profit forecast, banking on rising demand for cartridges and syringes used to manufacture injectable therapies.
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
West Pharmaceutical Services on Thursday beat quarterly profit estimates and raised its annual profit forecast, banking on rising demand for cartridges and syringes used to manufacture injectable therapies.
04/25 06:00 EST - prnewswire.com
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
04/24 13:16 EST - zacks.com
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
04/22 10:46 EST - zacks.com
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
04/19 10:16 EST - forbes.com
Ex-Dividend Reminder: Lennar, Lowe's And West Pharmaceutical
On 4/23/24, Lennar, Lowe's Companies and West Pharmaceutical Services, will all trade ex-dividend for their respective upcoming dividends. Lennar will pay its quarterly dividend of $0.50 on 5/8/24, Lowe's Companies will pay its quarterly dividend of $1.10 on 5/8/24, and West Pharmaceutical Services will pay its quarterly dividend of $0.20 on 5/1/24.
Ex-Dividend Reminder: Lennar, Lowe's And West Pharmaceutical
On 4/23/24, Lennar, Lowe's Companies and West Pharmaceutical Services, will all trade ex-dividend for their respective upcoming dividends. Lennar will pay its quarterly dividend of $0.50 on 5/8/24, Lowe's Companies will pay its quarterly dividend of $1.10 on 5/8/24, and West Pharmaceutical Services will pay its quarterly dividend of $0.20 on 5/1/24.
04/18 11:07 EST - zacks.com
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/17 08:46 EST - zacks.com
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
04/11 06:00 EST - prnewswire.com
West to Host First-Quarter 2024 Conference Call
EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
West to Host First-Quarter 2024 Conference Call
EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
03/14 18:49 EST - investorplace.com
3 Pharma Stocks to Sell in March Before They Crash & Burn
Recent trends in the stock market have seen a shift in investor interest from tech giants, known as the Magnificent 7, towards pharmaceutical companies, particularly those involved in weight-loss drugs. But, it's important to identify which pharma stocks to sell before they plummet, as not all will benefit equally from the hype.
3 Pharma Stocks to Sell in March Before They Crash & Burn
Recent trends in the stock market have seen a shift in investor interest from tech giants, known as the Magnificent 7, towards pharmaceutical companies, particularly those involved in weight-loss drugs. But, it's important to identify which pharma stocks to sell before they plummet, as not all will benefit equally from the hype.
03/13 08:01 EST - zacks.com
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
02/28 16:30 EST - prnewswire.com
West to Participate in Upcoming Investor Conferences
EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET. It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.
West to Participate in Upcoming Investor Conferences
EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET. It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.
02/27 23:36 EST - seekingalpha.com
Why West Pharma Is Far From Done
West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-value products and strategic collaborations, positioning it for future growth in the healthcare sector. Despite current challenges and a somewhat lofty valuation, projected earnings growth suggests the potential for significant long-term returns.
Why West Pharma Is Far From Done
West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-value products and strategic collaborations, positioning it for future growth in the healthcare sector. Despite current challenges and a somewhat lofty valuation, projected earnings growth suggests the potential for significant long-term returns.
02/20 06:00 EST - prnewswire.com
West Announces Second-Quarter 2024 Dividend
EXTON, Pa. , Feb. 20, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2024 dividend of $0.20 per share. The dividend will be paid on May 1, 2024, to shareholders of record as of April 24, 2024.
West Announces Second-Quarter 2024 Dividend
EXTON, Pa. , Feb. 20, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2024 dividend of $0.20 per share. The dividend will be paid on May 1, 2024, to shareholders of record as of April 24, 2024.
02/15 14:35 EST - zacks.com
West Pharmaceutical (WST) Beats on Q4 Earnings, HVP Drives Sales
West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
West Pharmaceutical (WST) Beats on Q4 Earnings, HVP Drives Sales
West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
02/15 14:05 EST - seekingalpha.com
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript